Performance of sodium iodide based 18F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses

British Journal of Radiology

Volumn 75, Issue 890, 2002, Pages 114-121

  Pitman, A G ^a   Hicks, R J ^a   Binns, D S ^a   Ware, R E ^a   Kalff, V ^a   McKenzie, A F ^a   Ball, D L ^a   MacManus, M P ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; SODIUM IODIDE;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; FOLLOW UP; HUMAN; LABORATORY DIAGNOSIS; LONG TERM CARE; LUNG ALVEOLUS CELL CARCINOMA; LUNG BIOPSY; LUNG CARCINOMA; LUNG METASTASIS; LUNG NODULE; LUNG SARCOIDOSIS; LUNG SURGERY; LUNG TUBERCULOSIS; LUNG TUMOR; MALIGNANT TRANSFORMATION; MEDICAL DOCUMENTATION; METASTASIS; NON INVASIVE MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; PREDICTION; SARCOMA; SENSITIVITY AND SPECIFICITY;

EID: 0036201364     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.75.890.750114     Document Type: Article

References (29)

1. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory
2. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application
3. Prospective investigation of positron emission tomography in lung nodules
4. Controlled prospective study of positron emission tomography using the glucose analogue [18F]fluorodeoxyglucose in the evaluation of pulmonary nodules
5. Differentiating benign from malignant lung lesions using 'quantitative' parameters of FDG PET images
6. Probability of malignancy in solitary pulmonary nodules using fluorine 18 FDG and PET
7. Evaluation of the solitary pulmonary nodule by positron emission tomography imaging
8. PET FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis
9. Continuous slice PENN-PET: A positron tomograph with volume imaging capability
10. Clinical evaluation of processing techniques for attenuation correction with Cs-137 in whole body PET imaging
11. Occupational exposure in nuclear medicine and PET
12. Volume imaging tomographs
13. PET in lung cancer
14. Efficacy of F-18 fluorodeoxyglucose positron emission tomography scans in diagnosis of pulmonary nodules
15. Can be standardised uptake value characterise primary brain tumours on FDG PET?
16. FDG PET: Elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies
17. Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG PET
18. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities
19. Mediastinal lymph node staging of non-small cell lung cancer: A prospective comparison of computed tomography and positron emission tomography
20. Whole body 18FDG positron emission tomography in the staging of non-small cell lung cancer
21. Staging non-small cell lung cancer by whole body positron emission tomographic imaging
22. Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling
23. Staging of mediastinal non-small cell lung cancer with FDG PET, CT and fusion images: Preliminary prospective evaluation
24. Staging non-small cell lung cancer with whole body PET
25. Cost effectiveness of FDG PET for staging non-small cell lung cancer: A decision analysis
26. Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - Meta-analytic comparison of PET and CT
27. Preoperative staging of non-small cell lung cancer with positron emission tomography
28. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in non-small-cell lung cancer: A prospective study